Department of Physiology and Anatomy, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas.
Am J Physiol Regul Integr Comp Physiol. 2022 Nov 1;323(5):R797-R809. doi: 10.1152/ajpregu.00086.2022. Epub 2022 Oct 3.
Dilutional hyponatremia associated with liver cirrhosis is due to inappropriate release of arginine vasopressin (AVP). Elevated plasma AVP causes water retention resulting in a decrease in plasma osmolality. Cirrhosis, in this study caused by ligation of the common bile duct (BDL), leads to a decrease in central vascular blood volume and hypotension, stimuli for nonosmotic AVP release. The A1/A2 neurons stimulate the release of AVP from the supraoptic nucleus (SON) in response to nonosmotic stimuli. We hypothesize that the A1/A2 noradrenergic neurons support chronic release of AVP in cirrhosis leading to dilutional hyponatremia. Adult, male rats were anesthetized with 2-3% isoflurane (mixed with 95% O/5% CO) and injected in the SON with anti-dopamine β-hydroxylase (DBH) saporin (DSAP) or vehicle followed by either BDL or sham surgery. Plasma copeptin, osmolality, and hematocrit were measured. Brains were processed for ΔFosB, dopamine β-hydroxylase (DBH), and AVP immunohistochemistry. DSAP injection: ) significantly reduced the number of DBH immunoreactive A1/A2 neurons (A1, < 0.0001; A2, = 0.0014), ) significantly reduced the number of A1/A2 neurons immunoreactive to both DBH and ΔFosB positive neurons (A1, = 0.0015; A2, < 0.0001), ) reduced the number of SON neurons immunoreactive to both AVP and ΔFosB ( < 0.0001), ) prevented the increase in plasma copeptin observed in vehicle-injected BDL rats ( = 0.0011), and ) normalized plasma osmolality and hematocrit (plasma osmolality, = 0.0475; hematocrit, = 0.0051) as compared with vehicle injection. Our data suggest that A1/A2 neurons contribute to increased plasma copeptin and hypoosmolality in male BDL rats.
与肝硬化相关的稀释性低钠血症是由于精氨酸加压素(AVP)的不当释放。升高的血浆 AVP 导致水潴留,从而降低血浆渗透压。在本研究中,通过结扎胆总管(BDL)导致中心血管血容量减少和低血压,这是刺激非渗透性 AVP 释放的刺激因素。A1/A2 神经元刺激视上核(SON)释放 AVP 以响应非渗透性刺激。我们假设 A1/A2 去甲肾上腺素能神经元支持肝硬化中 AVP 的慢性释放,导致稀释性低钠血症。成年雄性大鼠用 2-3%异氟烷(与 95% O/5% CO 混合)麻醉,并在 SON 中注射抗多巴胺 β-羟化酶(DBH)SAPORIN(DSAP)或载体,然后进行 BDL 或假手术。测量血浆 copeptin、渗透压和血细胞比容。大脑进行 ΔFosB、多巴胺 β-羟化酶(DBH)和 AVP 免疫组织化学处理。DSAP 注射:i)显著减少 DBH 免疫反应性 A1/A2 神经元的数量(A1, < 0.0001;A2, = 0.0014),ii)显著减少同时对 DBH 和 ΔFosB 阳性神经元具有免疫反应性的 A1/A2 神经元的数量(A1, = 0.0015;A2, < 0.0001),iii)减少同时对 AVP 和 ΔFosB 具有免疫反应性的 SON 神经元的数量( < 0.0001),iv)防止在车辆注射 BDL 大鼠中观察到的血浆 copeptin 增加( = 0.0011),v)使血浆渗透压和血细胞比容正常化(血浆渗透压, = 0.0475;血细胞比容, = 0.0051)与载体注射相比。我们的数据表明,A1/A2 神经元有助于增加男性 BDL 大鼠的血浆 copeptin 和低渗透压。